MAKE SURE YOUR DENTIST IS AN ADA MEMBER!:
ADA Members Adhere to Strict Code of Ethics and Conduct. You should make sure you are SEEING AN ADA MEMBER DENTIST!
Visit ADA Find-A-Dentist to Find One Near YOU
Ninth District Headquarters Office - Hawthorne, NY
2025 Ninth District President
Dr. Renuka Bijoor
CE Registry is now CE Navigator
Navigate your continuing education journey with ease using the CE Navigator, your ultimate guide to professional development.
Life comes with challenges, but your new Member Assistance Program (MAP) is here to help. This free, confidential benefit is available to you and your household, offering resources and services to support mental health, reduce stress, and make life easier.
The Ninth District Dental Society was formed in 1909 and renamed to the Ninth District Dental Association in 2002. We have a membership of over 1500 dentists in 5 counties: Westchester, Rockland, Dutchess, Orange and Putnam.
In its quest to serve both the public and the profession, the Ninth District embodies the highest ideals.
The mission of the 9th District Dental Association is to serve and support its members and the public by improving the oral health of our community through Advocacy, Continuing Education and Camaraderie.
Latest News Around the Tripartite
FDA Issues Health Care Stakeholders Update
Apr 5, 2024
The United States Food and Drug Administration (FDA) has issued its weekly regulatory update for stakeholders. You can read the FDA regulatory update for stakeholders below.
April 5, 2024 Dear Colleague, While the FDA continues to focus on protecting the public’s health, using science to guide our decisions, and facilitating access to critical medical products, we also recognize the work of our public health partners. As public health advocates, we know that your work to better our country is invaluable. Your partnership, knowledge and engagement in the public health space are appreciated.
It’s National Minority Health Month and this year’s theme is “Be the Source for Better Health.” We invite everyone to be the source for clinical trial information. Share our clinical trial resources, available in Spanish and other languages: https://www.fda.gov/.../minority.../clinical-trial-diversity
Consumer Updates
Colorectal Cancer: What You Should Know About Screening The evidence is clear - screening for colorectal cancer may save your life. Today, more and more people are choosing colorectal cancer screening. As a result, there is a steady decline in the number of older people getting and dying from colorectal cancer. Lower rates of smoking among Americans have also contributed to the decline in the past several years.
Is Food Safe if it Has Chemicals? You may have seen news or online content about chemicals in our foods. Perhaps you’re wondering, is a food safe to eat if it contains chemicals? All our food — like everything in the world — is made up of chemicals. The presence of a chemical alone isn’t what determines whether a food is safe to eat.
Know Which Medication Is Right for Your Seasonal Allergies Seasonal allergic rhinitis, the medical term for seasonal allergies and hay fever, can also trigger or worsen asthma and lead to other health problems, such as sinus infections (sinusitis) and ear infections. The U.S. Food and Drug Administration regulates several medications that offer allergy relief.
Data Integrity for In Vivo Bioavailability and Bioequivalence Studies The purpose of this guidance is to provide recommendations to applicants and testing site management on achieving and maintaining data integrity for the clinical and bioanalytical portions of bioavailability (BA) and bioequivalence (BE) studies submitted in support of investigational new drug applications (INDs), new drug applications (NDAs), and abbreviated new drug applications (ANDAs), and the bioanalytical portion of clinical pharmacologic studies supporting CDER-regulated biologic license applications (BLAs) as well as amendments and supplements to these applications.
Electronic Submission of Expedited Safety Reports From IND-Exempt BA/BE Studies Guidance for Industry This guidance provides instructions for the electronic submission of expedited individual case safety reports (ICSRs) from investigational new drug (IND)-exempt bioavailability (BA)/bioequivalence (BE) studies conducted to support abbreviated new drug applications (ANDAs) to FDA Adverse Event Reporting System (FAERS).
Providing Regulatory Submissions in Electronic Format: IND Safety Reports Guidance for Industry FDA is announcing the availability of a final guidance for industry entitled “Providing Regulatory Submissions in Electronic Format: IND Safety Reports.” This guidance finalizes the draft guidance of the same name published on October 30, 2019 (84 FR 58158), and describes the electronic format sponsors will be required to use when they electronically submit IND safety reports to CDER and CBER for serious and unexpected suspected adverse reactions, as required under 21 CFR 312.32(c)(1)(i).
The Stakeholder Engagement Staff resides within the Office of the Commissioner and falls under the Office of External Affairs. We aim to build stronger relationships with health professional organizations, consumer groups, trade associations, patient advocacy organizations, think tanks/academia, and other stakeholders, in order to better inform our policy making process, identify policy hurdles or stakeholder misconceptions, and create strategic collaborations. For more information, please contact us at: FDAStakeholderEngagement@fda.hhs.gov.
Dentin hypersensitivity has traditionally been treated with over-the-counter dentifrice compounds. Treatment times/relief factors varied. Mr. Calderon will discuss the latest treatment modalities available.
.png?sfvrsn=4447de7f_1)
